AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript February 4, 2026
AbbVie Inc. beats earnings expectations. Reported EPS is $2.71, expectations were $2.65.
Operator: Good morning, and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2025 Earnings Conference Call. All participants will be able to listen only until the question and answer portion of this call. Today’s call is also being recorded. If you have any objections, you may disconnect at this time. I would now...
